$OPK.US Health jumped after agreeing to sell select BioReference assets to Labcorp for up to $872 million.
The deal includes $722 million in cash at closing, plus potential additional payments tied to future performance. The sale is expected to streamline operations and free capital as OPKO shifts further toward its biopharma focus.
#OPK #OPKO #Labcorp #Healthcare #CoinVahini